EVEscape uses evolutionary and biological information to predict how a virus could change to escape the immune system.

A team led by investigators at Massachusetts General Hospital has determined that Omicron BA.2 is weaker than both Delta and the original Omicron variant.

Reductions in surgical procedures precipitated by SARS-CoV-2 have not fully returned to their pre-pandemic levels, resulting in severe backlogs and deferred surgeries.

Harvard T.H. Chan School of Public Health Professor William Hanage explains how to stay on guard against subvariants, noting role of protective measures in transition to new pandemic phase.

Harvard scientists give their read on recent COVID data from the U.S. and South Africa.

Subvariant is rising in the region, but no sign of dramatic surge in cases that other nations have experienced.

Harvard’s William Hanage, an epidemiologist and associate professor at the Harvard T.H. Chan School of Public Health, outlines what an endemic SARS-CoV-2 might look like.

New study reveals that living through the COVID-19 pandemic may trigger brain inflammation that contributes to fatigue, concentration difficulties, and depression.

Harvard Med specialist says cases of remdesivir-resistant disease seem rare, may not become big issue.

A new study led by Harvard researchers models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments.